These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20403575)

  • 1. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
    Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
    Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cord blood stem cells and the journey to a cure for type 1 diabetes.
    Zhao Y; Mazzone T
    Autoimmun Rev; 2010 Dec; 10(2):103-7. PubMed ID: 20728583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulation of blood-derived stem cell as a comprehensive tool for treating type 1 diabetes.
    Zhao Y; Hwang D; Guo C
    Discov Med; 2009 Dec; 8(43):219-22. PubMed ID: 20040273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.
    Zhao Y; Lin B; Darflinger R; Zhang Y; Holterman MJ; Skidgel RA
    PLoS One; 2009; 4(1):e4226. PubMed ID: 19156219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
    Jaeckel E; Mpofu N; Saal N; Manns MP
    Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.
    Chaturvedi P; Qin HY; Chou H; Singh B
    Crit Rev Immunol; 1997; 17(5-6):519-28. PubMed ID: 9419439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
    Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK
    Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Niens M; Kulik J; Dilorenzo TP
    Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
    Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
    Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.